Mainz Biomed N.V. (NASDAQ: QUCY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MAINZ BIOMED N.V.

Mainz Biomed N.V. (NASDAQ: QUCY)
Listen to this Section

$1.36
N/A ( 0% ) 5.7K

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Market Data
Open $1.36
Previous Close $1.36
Volume 5.7K
Market Cap $30.96M
Day Range $1.36 - $1.38
52 Week Range $0.30 - $4.93
Shares Outstanding 22.77M
Change % 0%
Net Change N/A
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings

No data available for selected period.

Latest News

About US

Services

Stay Connected